51.Which of the following weight-loss products has Health Canada placed : 1401629.
51.Which of the following weight-loss products has Health Canada placed a partial ban on its sale?
a.ephedrine
b.yohimbine
c.chromium
d.chitosan
52.What is the primary reason that laxatives are generally ineffective agents for losing weight?
a.They have little, if any, effect on appetite.
b.They have a low binding activity to dietary fat.
c.They act on the large intestine rather than the small intestine.
d.They often induce abdominal cramping and intestinal gas, thereby encouraging rejection and noncompliance.
53.Over-the-counter products labelled as “dieter’s tea” are reported to lead to which of these symptoms?
a.leptin resistance
b.ketone poisoning
c.cravings for protein
d.nausea and diarrhea
54.Fraudulent weight reduction literature refers to visually apparent, lumpy forms of body fat as which of these terms?
a.lipomas
b.lipidosis
c.cellulite
d.hyperphagic deposits
55.Clinically severe obesity is also known as which of these terms?
a.morbid obesity
b.metabolic syndrome
c.leptin-resistant obesity
d.psychological-resistant syndrome
56.Bariatrics is a field of medicine that specializes in the treatment of which of these states?
a.obesity
b.addiction to weight-loss drugs
c.severe underweight
d.anorexia and bulimia
57.Which one of the following criterion would allow a patient to become a candidate for weight-loss surgery?
a.BMI higher than 40
b.a medical condition such as seizures or a heart attack
c.BMI higher than 30
d.drug therapy has been unsuccessful
58.Which of the following neurotransmitters is released by the weight-loss drugs phentermine and diethyproprion?
a.epinephrine
b.dopamine
c.serotonin
d.norepinephrine
59.Mr. Sinclair has a BMI of 43 and is taking drugs to lose weight. He has heard that some drugs cause lots of gastrointestinal discomfort and he wants a drug with fewer side effects. Which of the following drugs should be prescribed for Mr. Sinclair?
a.olestra
b.orlistat
c.serotonin
d.phentermine
60.How does orlistat function in the body to promote weight loss?
a.orlistat reduces taste sensation.
b.orlistat inhibits lipoprotein lipase.
c.orlistat inhibits pancreatic lipase.
d.orlistat alters circulating leptin concentrations.
51.Which of the following weight-loss products has Health Canada placed : 1401629